Mendelson G, Aronow W S
Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, New York, USA.
J Am Geriatr Soc. 1997 Nov;45(11):1360-1. doi: 10.1111/j.1532-5415.1997.tb02936.x.
To investigate the prevalence of beta-blocker use in older persons with prior myocardial infarction (MI) or coronary artery disease (CAD) without contraindications to beta-blockers in an academic hospital-based geriatrics practice.
A retrospective analysis of charts from all older patients seen during January 1996 through March 1997 at an academic, hospital-based geriatrics practice was performed to investigate the prevalence of beta-blocker use in older patients with prior MI or CAD without contraindications to beta blockers.
An academic, hospital-based, primary care geriatrics practice staffed by fellows in a geriatrics training program and full-time faculty geriatricians.
One hundred thirty-nine women and 84 men, mean age 82 +/- 8 years (range 67 to 96), were included in the study.
Of 233 patients with CAD, 53 patients (23%) were receiving beta-blockers. Of 180 patients with CAD not receiving beta-blockers, 34 patients (19%) had contraindications to beta-blockers. Of 199 patients with CAD without contraindications to beta-blockers, 53 patients (27%) were receiving beta blockers. Of 162 patients with prior MI, 38 patients (23%) were receiving beta-blockers. Of 124 patients with prior MI not receiving beta-blockers, 19 patients (15%) had contraindications to beta-blockers. Of 143 patients with prior MI without contraindications to beta-blockers, 38 patients (27%) were receiving beta-blockers.
There is marked underutilization of beta-blockers in treating older patients with prior MI or CAD in an academic, hospital-based geriatrics practice.
在一家以学术医院为基础的老年医学实践机构中,调查在无β受体阻滞剂使用禁忌证的既往有心肌梗死(MI)或冠状动脉疾病(CAD)的老年人中β受体阻滞剂的使用情况。
对1996年1月至1997年3月期间在一家以学术医院为基础的老年医学实践机构就诊的所有老年患者的病历进行回顾性分析,以调查在无β受体阻滞剂使用禁忌证的既往有MI或CAD的老年患者中β受体阻滞剂的使用情况。
一家以学术医院为基础的初级保健老年医学实践机构,由老年医学培训项目的研究员和全职老年病科医生组成。
139名女性和84名男性纳入研究,平均年龄82±8岁(范围67至96岁)。
在233例CAD患者中,53例(23%)正在接受β受体阻滞剂治疗。在180例未接受β受体阻滞剂治疗的CAD患者中,34例(19%)有β受体阻滞剂使用禁忌证。在199例无β受体阻滞剂使用禁忌证的CAD患者中,53例(27%)正在接受β受体阻滞剂治疗。在162例既往有MI的患者中,38例(23%)正在接受β受体阻滞剂治疗。在124例未接受β受体阻滞剂治疗的既往有MI的患者中,19例(15%)有β受体阻滞剂使用禁忌证。在143例无β受体阻滞剂使用禁忌证的既往有MI的患者中,38例(27%)正在接受β受体阻滞剂治疗。
在一家以学术医院为基础的老年医学实践机构中,在治疗既往有MI或CAD的老年患者时,β受体阻滞剂的使用明显不足。